It was previously shown that RS504393 (a CCR2 antagonist) and maraviroc (a CCR5 antagonist) both relieve neuropathic pain symptoms in a rat model of neuropathy (8, 20, 21) and simultaneously enhance the effectiveness of morphine (22, 23). Here, CCR5 is linked to neuropathy.